Huiyan Qu

534 total citations
29 papers, 366 citations indexed

About

Huiyan Qu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Complementary and alternative medicine. According to data from OpenAlex, Huiyan Qu has authored 29 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Cardiology and Cardiovascular Medicine and 5 papers in Complementary and alternative medicine. Recurrent topics in Huiyan Qu's work include Cardiac Fibrosis and Remodeling (11 papers), Traditional Chinese Medicine Analysis (5 papers) and Cardiovascular Function and Risk Factors (4 papers). Huiyan Qu is often cited by papers focused on Cardiac Fibrosis and Remodeling (11 papers), Traditional Chinese Medicine Analysis (5 papers) and Cardiovascular Function and Risk Factors (4 papers). Huiyan Qu collaborates with scholars based in China, United States and Romania. Huiyan Qu's co-authors include Hua Zhou, Tao Yang, Xiaoqing Zhang, Qian Liu, Xiaolong Song, Zongguo Yang, Tianshu Yang, Xiaoni Kong, Xiaoli Yang and Xinting Wang and has published in prestigious journals such as Frontiers in Immunology, Journal of Ethnopharmacology and Ecotoxicology and Environmental Safety.

In The Last Decade

Huiyan Qu

28 papers receiving 358 citations

Peers

Huiyan Qu
Huiyan Qu
Citations per year, relative to Huiyan Qu Huiyan Qu (= 1×) peers Bingxuan Zhang

Countries citing papers authored by Huiyan Qu

Since Specialization
Citations

This map shows the geographic impact of Huiyan Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiyan Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiyan Qu more than expected).

Fields of papers citing papers by Huiyan Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huiyan Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiyan Qu. The network helps show where Huiyan Qu may publish in the future.

Co-authorship network of co-authors of Huiyan Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Huiyan Qu. A scholar is included among the top collaborators of Huiyan Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huiyan Qu. Huiyan Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Xie, Weidong, et al.. (2024). Exosome miRNA profile and mitigating effect of miR-23a-3p/Cul3 axis on apoptosis in the pathogenesis of SiO2 dust-induced lung fibrosis. Ecotoxicology and Environmental Safety. 283. 116971–116971. 2 indexed citations
3.
Qu, Huiyan, et al.. (2024). Extreme temperature events, functional dependency, and cardiometabolic multimorbidity: Insights from a national cohort study in China. Ecotoxicology and Environmental Safety. 284. 117013–117013. 5 indexed citations
4.
Wang, Xinting, et al.. (2024). LuQi formula attenuates Cardiomyocyte ferroptosis via activating Nrf2/GPX4 signaling axis in heart failure. Phytomedicine. 125. 155357–155357. 12 indexed citations
5.
Cheng, Peipei, Xinting Wang, Qian Liu, et al.. (2024). Nrf2 mediated signaling axis in heart failure: Potential pharmacological receptor. Pharmacological Research. 206. 107268–107268. 6 indexed citations
6.
Qu, Huiyan, et al.. (2023). The therapeutic effect of exosomal lncRNA MSTRG.91634.7 on mitochondrial dysfunction during SiO2-induced lung fibrosis. International Immunopharmacology. 121. 110508–110508. 3 indexed citations
7.
Hu, Yiran, Huiyan Qu, & Hua Zhou. (2023). Integrating Network Pharmacology and an Experimental Model to Investigatethe Effect of Zhenwu Decoction on Doxorubicin-Induced Heart Failure. Combinatorial Chemistry & High Throughput Screening. 26(14). 2502–2516. 5 indexed citations
8.
Wang, Xinting, Qian Liu, Tianshu Yang, et al.. (2023). Targeting regulatory T cells for cardiovascular diseases. Frontiers in Immunology. 14. 1126761–1126761. 22 indexed citations
9.
Xi, Zhichao, et al.. (2023). LuQi Formula relieves ventricular remodeling through improvement of HIF-1α-mediated intestinal barrier integrity. Chinese Medicine. 18(1). 90–90. 4 indexed citations
10.
Wang, Xinting, et al.. (2023). Extracellular vesicles mediate biological information delivery: A double-edged sword in cardiac remodeling after myocardial infarction. Frontiers in Pharmacology. 14. 1067992–1067992. 11 indexed citations
11.
Zhang, Xiaoqing, Huiyan Qu, Tao Yang, et al.. (2022). LuQi Formula Ameliorates Myocardial Fibrosis by Suppressing TLR4/MyD88/NF-κB Pathway and NLRP3 Inflammasome Activation in Mice with Myocardial Infarction. Evidence-based Complementary and Alternative Medicine. 2022. 1–11. 2 indexed citations
12.
Feng, Jiling, Xiaoqing Zhang, Huiyan Qu, et al.. (2022). Luhong Formula and Hydroxysafflor yellow A protect cardiomyocytes by inhibiting autophagy. Phytomedicine. 110. 154636–154636. 13 indexed citations
13.
Zhao, Dandan, Xiaoqing Zhang, Tao Yang, et al.. (2021). Exploring the Therapeutic Mechanism of Tingli Dazao Xiefei Decoction on Heart Failure Based on Network Pharmacology and Experimental Study. Evidence-based Complementary and Alternative Medicine. 2021. 1–15. 9 indexed citations
14.
Zhang, Xiaoqing, Dandan Zhao, Jiling Feng, et al.. (2021). LuQi Formula Regulates NLRP3 Inflammasome to Relieve Myocardial-Infarction-Induced Cardiac Remodeling in Mice. Evidence-based Complementary and Alternative Medicine. 2021. 1–14. 16 indexed citations
15.
Zhang, Xiaoqing, Huiyan Qu, Tao Yang, Xiaoni Kong, & Hua Zhou. (2021). Regulation and functions of NLRP3 inflammasome in cardiac fibrosis: Current knowledge and clinical significance. Biomedicine & Pharmacotherapy. 143. 112219–112219. 29 indexed citations
16.
Liu, Qian, et al.. (2020). Luhong Formula Has a Cardioprotective Effect on Left Ventricular Remodeling in Pressure‐Overloaded Rats. Evidence-based Complementary and Alternative Medicine. 2020(1). 4095967–4095967. 11 indexed citations
17.
Yang, Tianshu, Huiyan Qu, Xiaolong Song, et al.. (2019). Luhong Granules Prevent Ventricular Remodelling after Myocardial Infarction by Reducing the Metabolites TMAO and LPS of the Intestinal Flora. Evidence-based Complementary and Alternative Medicine. 2019. 1–10. 15 indexed citations
18.
Qu, Huiyan, et al.. (2017). Luhong formula inhibits myocardial fibrosis in a paracrine manner by activating the gp130/JAK2/STAT3 pathway in cardiomyocytes. Journal of Ethnopharmacology. 202. 28–37. 18 indexed citations
19.
Qu, Huiyan, Zhongyu Li, Mingfeng Tang, et al.. (2015). Induction of substantial myocardial regeneration by an active fraction of the Chinese herb Rosa laevigata Michx. BMC Complementary and Alternative Medicine. 15(1). 359–359. 4 indexed citations
20.
Zhou, Hua, et al.. (2014). Effect of Shenxinning decoction on ventricular remodeling in AT1 receptor-knockout mice with chronic renal insufficiency. Indian Journal of Pharmacology. 46(4). 391–391. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026